MoreThe novel hip implant features a monoblock ceramic acetabular cup for
use in articulating joints for total joint replacement.
Amedica® Corp. has been granted U. S. patent number 7,695,521 for its novel hip implant, which features a monoblock ceramic acetabular cup for use in articulating joints for total joint replacement. Currently under development, Amedica's cup covered under this and other pending patents will be used as an ultra-low-wear-bearing component for motion-preserving implants.
The ceramic manufacturing capability of the technology will help surgeons to achieve more successful outcomes in restoring patient function, allowing individuals to return to productive and pain-free lives, said Ben Shappley, president, CEO and director of Amedica.
"Our unique technology allows us to combine our high-strength silicon nitride ceramic with an ultra-low-wear surface-bearing technology along with a bone-contacting BioactiveTM surface designed for secure, long-term fixation," Shappley said. "This provides surgeons with wider design choices and flexibility to improve anatomic fit and function compared to currently available alternate bearing options.
"The monoblock ceramic technology covered by this patent and other issued and pending patents represents a major advance in orthopaedic implants and other applications. With this bearing technology, we expect to bring significant benefit to both patients and surgeons alike.”
For more information, visit www.amedicacorp.com.
Amedica® Corp. has been granted U. S. patent number 7,695,521 for its novel hip implant, which features a monoblock ceramic acetabular cup for use in articulating joints for total joint replacement. Currently under development, Amedica's cup covered under this and other pending patents will be used as an ultra-low-wear-bearing component for motion-preserving implants.
The ceramic manufacturing capability of the technology will help surgeons to achieve more successful outcomes in restoring patient function, allowing individuals to return to productive and pain-free lives, said Ben Shappley, president, CEO and director of Amedica.
"Our unique technology allows us to combine our high-strength silicon nitride ceramic with an ultra-low-wear surface-bearing technology along with a bone-contacting BioactiveTM surface designed for secure, long-term fixation," Shappley said. "This provides surgeons with wider design choices and flexibility to improve anatomic fit and function compared to currently available alternate bearing options.
"The monoblock ceramic technology covered by this patent and other issued and pending patents represents a major advance in orthopaedic implants and other applications. With this bearing technology, we expect to bring significant benefit to both patients and surgeons alike.”
For more information, visit www.amedicacorp.com.
With access to over one million professionals and more than 60 industry-specific publications,
